je.st
news
Amgen, Novartis collaborate for Alzheimer's disease and migraine programs
2015-09-02 11:50:57| Biotech - Topix.net
Amgen today announced a neuroscience collaboration with Novartis in the areas of Alzheimer's disease and migraine. The collaboration accelerates Amgen's potential entry into Alzheimer's disease by teaming up with Novartis on a differentiated and genetically validated Alzheimer's disease program directed at genetically predisposed individuals at risk of developing Alzheimer's disease.
Tags: programs
disease
collaborate
migraine
Category:Biotechnology and Pharmaceuticals